Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TPI1 | P60174 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12936166 | 0.85 | HPGD (0.39) | TPI1 | |
| SCHEMBL11966757 | 0.80 | SMN1; SMN2 (0.39) | TPI1 | |
| SCHEMBL9971737 | 0.79 | TPI1 (0.31) | TPI1 | |
| SCHEMBL11966756 | 0.77 | — | — | |
| SCHEMBL26556407 | 0.76 | BBOX1 (0.37) | — | |
| SCHEMBL100397 | 0.75 | MVD (0.38) | — | |
| SCHEMBL11966759 | 0.75 | TSHR (0.31) | — | |
| SCHEMBL10029196 | 0.75 | — | — | |
| SCHEMBL11966760 | 0.70 | — | — | |
| SCHEMBL100398 | 0.69 | TSHR (0.40) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9347031-B2 | Container for forming a cell aggregate and a method for forming a cell aggregate | SHISEIDO COMPANY, LTD. (JP) | 2016-05-24 | — | — | US | disclosed |
| US-20130266954-A1 | METHOD FOR FORMING A CELL AGGREGATE | SHISEIDO COMPANY, LTD. (JP) | 2013-10-10 | — | — | US | disclosed |
| US-8242222-B2 | Polysiloxane, acrylic compound and vinylic compound | SHISEIDO COMPANY, LTD. (JP) | 2012-08-14 | — | — | US | disclosed |
| US-8222443-B2 | Phosphorylcholine group-containing compound, method of manufacturing a phosphorylcholine group-containing compound, surface-modifying agent, and a method of modifying a surface using a surface-modifying agent | SHISEIDO COMPANY, LTD. (JP) | 2012-07-17 | — | — | US | disclosed |
| US-20120156696-A1 | container for forming a cell aggregate and a method for forming a cell aggregate | SHISEIDO COMPANY, LTD. (JP) | 2012-06-21 | — | — | US | disclosed |
| US-20120034709-A1 | SURFACE MODIFIED SUBSTRATE, BIOTIP AND A METHOD FOR PRODUCING THEREOF | SHISEIDO COMPANY, LTD. (JP) | 2012-02-09 | — | — | US | disclosed |
| US-20110040053-A1 | POLYSILOXANE, ACRYLIC COMPOUND AND VINYLIC COMPOUND | SHISEIDO COMPANY, LTD. (JP) | 2011-02-17 | — | — | US | disclosed |
| US-20100113817-A1 | PHOSPHORYLCHOLINE GROUP-CONTAINING COMPOUND, METHOD OF MANUFACTURING A PHOSPHORYLCHOLINE GROUP-CONTAINING COMPOUND, SURFACE-MODIFYING AGENT, AND A METHOD OF MODIFYING A SURFACE USING A SURFACE-MODIFYING AGENT | SHISEIDO COMPANY, LTD. (JP) | 2010-05-06 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100113817-A1 | PHOSPHORYLCHOLINE GROUP-CONTAINING COMPOUND, METHOD OF MANUFACTURING A PHOSPHORYLCHOLINE GROUP-CONTAINING COMPOUND, SURFACE-MODIFYING AGENT, AND A METHOD OF MODIFYING A SURFACE USING A SURFACE-MODIFYING AGENT | PHOSPHO1, SGMS1, SGMS2 | TPI1 2799/4885 |
| US-20110040053-A1 | POLYSILOXANE, ACRYLIC COMPOUND AND VINYLIC COMPOUND | ASH2L, SMC2, MUS81 | TPI1 3325/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.